Document is current
Any future updates will be listed below
-
Authors
Qiang, Hantao https://orcid.org/0009-0006-9479-6717
Wang, Fei
Lu, Wenyun https://orcid.org/0000-0003-1787-2617
Xing, Xi
Kim, Hahn
Mérette, Sandrine A. M.
Ayres, Lucas B.
Oler, Eponine
AbuSalim, Jenna E.
Roichman, Asael
Neinast, Michael
Cordova, Ricardo A.
Lee, Won Dong https://orcid.org/0000-0002-2344-171X
Herbst, Ehud https://orcid.org/0000-0002-5570-5804
Gupta, Vishu
Neff, Samuel L. https://orcid.org/0000-0002-5993-8445
Hiebert-Giesbrecht, Mickel https://orcid.org/0000-0003-2947-187X
Young, Adamo
Gautam, Vasuk
Tian, Siyang
Wang, Bo https://orcid.org/0000-0002-9620-3413
Röst, Hannes https://orcid.org/0000-0003-0990-7488
Baidwan, Jatinder
Greiner, Russell https://orcid.org/0000-0001-8327-934X
Chen, Li https://orcid.org/0000-0001-8685-3466
Johnston, Chad W.
Foster, Leonard J. https://orcid.org/0000-0001-8551-4817
Shapiro, Aaron M. https://orcid.org/0000-0002-9920-1763
Wishart, David S.
Rabinowitz, Joshua D. https://orcid.org/0000-0002-1247-4727
Skinnider, Michael A. https://orcid.org/0000-0002-2168-1621
- License Information
-
More Information
Article History
Received: 13 November 2024
Accepted: 26 November 2025
First Online: 14 January 2026
Competing interests
: J.D.R. is a member of the Rutgers Cancer Institute of New Jersey (RCINJ) and the University of Pennsylvania Diabetes Research Center (U Penn DRC); a director of the U Penn DRC-Princeton inter-institutional metabolomics core and RCINJ metabolomics core; an advisor and stockholder of Colorado Research Partners, Bantam Pharmaceuticals, Barer Institute, Rafael Pharmaceuticals, Empress Therapeutics and Marea Therapeutics; a founder, director, and stockholder of Farber Partners, Raze Therapeutics and Sofro Pharmaceuticals; and a founder, advisor, and stockholder of Marea Therapeutics and Fargo Biotechnologies. H.K. is a member of the Rutgers Cancer Institute of New Jersey (RCINJ); a co-founder, director, stockholder and consultant for Crescenta Biosciences; a co-founder, director, stockholder for Farber Partners; a co-founder and shareholder of Chiromics; a shareholder and scientific advisor to Colorado Research Partners and Integrated Biosciences. M.A.S. is a member of the Rutgers Cancer Institute of New Jersey (RCINJ). H.K. and J.D.R. are inventors on patents held by Princeton University. The other authors declare no competing interests.
